Tuesday, June, 25, 2019 08:49:01

Category: Biotechnology

TLC and 3SBio partner to commercialize two NanoX products in China

A clinical-stage specialty pharmaceutical company Taiwan Liposome Company Ltd. and 3SBio Inc, China’s leading biopharmaceutical company have reportedly  entered into an exclusive partnership intended to commercialize two liposomal products in China, using TLC’s proprietary NanoX technology platform. As per the alliance, TLC and 3SBio will …

Diploid & Genomenon team up to advance rare disease diagnostics

In a major effort to develop genome interpretation for the rare disease diagnostics, Genomenon, a top genomic research company, and Diploid, a prominent AI-based software company for rare disease diagnostics, have reportedly inked a partnership deal. Sources with the knowledge of the matter stated that …

MeiraGTx and Janssen to develop gene therapies for IRD treatments

The latest transaction is the second significant collaboration by the two companies MeiraGTx Holdings Plc, a clinical-stage gene therapy company, has reportedly inked a strategic collaboration agreement with Janssen Pharmaceuticals, Inc., in a bid to develop and commercialize gene therapies for the IRD (inherited retinal …